About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalTaiwan
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
1
As Collaborator
1
Total Enrollment
180
By Phase
PHASE1/PHASE2: 2
By Status
RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05756322Lead Sponsor
The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
PHASE1/PHASE2Recruiting
90 participants
Started: Jul 20, 2023 · Completed: Dec 31, 2026
NCT05756322Collaborator
The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
PHASE1/PHASE2Recruiting
90 participants
Started: Jul 20, 2023 · Completed: Dec 31, 2026
Locations (1)
Headquarters
Taipei, Taiwan
Map
Loading map...